Value Bridge — MEMORIAL HOSPITAL FOR CANCER AND ALL
Current $-217M → Target $-121M (+$96.0M)
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-217.2M
Current EBITDA
$-121.2M
Target EBITDA
+$96.0M
Total Uplift
7
Value Levers
EBITDA Bridge — 7 Lever Model
Each lever shows gross impact, probability of achievement, and probability-weighted value.
Denial Rate Reduction
$0.0M
AR Acceleration
$0.0M
Coding Accuracy Uplift
$21.7M
Payer Mix Optimization
$52.1M
Cost to Collect Reduction
$17.4M
Clean Claim Improvement
$13.0M
Volume & Rate Growth
$86.9M
What This Means
The 7-lever model projects a 0% EBITDA uplift from $-217M to $-121M. The highest-impact lever is Volume & Rate Growth at $34.8M probability-weighted.
IC talking point: "We see $96M in annual EBITDA improvement, primarily from volume & rate growth. At an 11x multiple, this represents $1056M in equity value creation."